Literature DB >> 16236090

Thyroid cancer review 1: presentation and investigation of thyroid cancer.

P Nix1, A Nicolaides, A P Coatesworth.   

Abstract

Thyroid cancer is uncommon with an estimated lifetime risk of 0.8% for women and 0.3% for men. The incidence appears to be increasing by 4% per year and is currently the eighth commonest cancer in women. Managing thyroid cancer is challenging, as no prospective randomised trials exist. Most of the information is derived from large patient cohorts in which therapy has not been randomly assigned. This is the first of the three review papers we have written on the management of thyroid cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16236090     DOI: 10.1111/j.1368-5031.2005.00671.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  11 in total

1.  The analysis of differential diagnosis of benign and malignant thyroid nodules based on ultrasound reports.

Authors:  Shumei Miao; Mang Jing; Rongrong Sheng; Dai Cui; Shan Lu; Xin Zhang; Shenqi Jing; Xiaoliang Zhang; Tao Shan; Hongwei Shan; Tingyu Xu; Bing Wang; Zhongmin Wang; Yun Liu
Journal:  Gland Surg       Date:  2020-06

2.  Lentivirus-mediated silencing of MPHOSPH8 inhibits MTC proliferation and enhances apoptosis.

Authors:  Peiyong Li; Weiping Yang; Baiyong Shen; Hongwei Li; Jiqi Yan
Journal:  Oncol Lett       Date:  2016-05-06       Impact factor: 2.967

3.  Evaluation of the diagnostic performance of contrast-enhanced ultrasound combined with BRAF V600E gene detection in nodules of unclear significance by thyroid fine-needle aspiration.

Authors:  Xi Zhu; Xuyang Peng; Lei Zhu; Lidan Xie; Feng Cheng; Bin Zhou
Journal:  Gland Surg       Date:  2021-01

4.  Nature and outcome of malignant goiter: a revisit.

Authors:  Mohamed Yasser Ibrahim Daoud
Journal:  Pan Afr Med J       Date:  2021-02-23

5.  Molecular profiling of thyroid cancer subtypes using large-scale text mining.

Authors:  Chengkun Wu; Jean-Marc Schwartz; Georg Brabant; Goran Nenadic
Journal:  BMC Med Genomics       Date:  2014-12-08       Impact factor: 3.063

6.  Association between the KRAS Gene Polymorphisms and Papillary Thyroid Carcinoma in a Chinese Han Population.

Authors:  Lifeng Ning; Wenwang Rao; Yaqin Yu; Xiaoli Liu; Yuchen Pan; Yuan Ma; Rui Liu; Shangchao Zhang; Hui Sun; Qiong Yu
Journal:  J Cancer       Date:  2016-12-09       Impact factor: 4.207

7.  Effects of Long-Term In Vivo Exposure to Di-2-Ethylhexylphthalate on Thyroid Hormones and the TSH/TSHR Signaling Pathways in Wistar Rats.

Authors:  Xinwen Dong; Jin Dong; Yue Zhao; Jipeng Guo; Zhanju Wang; Mingqi Liu; Yunbo Zhang; Xiaolin Na
Journal:  Int J Environ Res Public Health       Date:  2017-01-04       Impact factor: 3.390

8.  Pattern of Thyroid Lesions in Western Region of Saudi Arabia: A Retrospective Analysis and Literature Review.

Authors:  Muhammad I Saeed; Amal Ali Hassan; Muhammad Ejaz Butt; Khalid Ali Baniyaseen; Muhammad I Siddiqui; Neda M Bogari; Faisal A Al-Allaf; Mohiuddin M Taher
Journal:  J Clin Med Res       Date:  2017-12-30

9.  Correlation between thyroid autoantibodies and the risk of thyroid papillary carcinoma.

Authors:  Xuyang Peng; Xi Zhu; Feng Cheng; Bin Zhou; Xiaohua Zhu; Lei Zhu
Journal:  Gland Surg       Date:  2020-08

10.  Emerging integrated nanoclay-facilitated drug delivery system for papillary thyroid cancer therapy.

Authors:  Yi Zhang; Mei Long; Peng Huang; Huaming Yang; Shi Chang; Yuehua Hu; Aidong Tang; Linfeng Mao
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.